Exosome Diagnostics Launches CLIA-Certified Laboratory

August 12, 2015 Leave a comment

Company centralizing U.S. operations ahead of cancer liquid biopsy test launches in 2015 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that it has opened a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in Cambridge, ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Clinical Laboratory Improvement Amendments

Exosome Diagnostics Launches CLIA-Certified Laboratory

Bacterial extracellular vesicles in the microbiome of first-pass meconium in newborn infants

Extracellular Vesicles – the cells’ secret messengers

Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling

Triple negative breast cancer-derived small extracellular vesicles as modulator of biomechanics in target cells

Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies

Characterization of extracellular vesicles from Lactiplantibacillus plantarum